Dr. Eric Marsh, M.D

Pediatrics Philadelphia, PA Male
NPI: 1821012204
Total Payments
$16,064
2024 Payments
$693.00
Companies
6
Transactions
45

Payment Breakdown by Category

Consulting$9,536 (59.4%)
Research$4,592 (28.6%)
Travel$1,265 (7.9%)
Food & Beverage$650.58 (4.0%)
Education$20.13 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $9,536 5 59.4%
Unspecified $4,592 25 28.6%
Travel and Lodging $1,265 5 7.9%
Food and Beverage $650.58 9 4.0%
Education $20.13 1 0.1%

Payments by Type

General
$11,472
20 transactions
Research
$4,592
25 transactions

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $7,292 27 $0 (2022)
Eisai Inc. $4,504 8 $0 (2017)
CIPLA USA INC. $2,000 1 $0 (2019)
GW Research Limited $1,439 7 $0 (2019)
EMD Serono, Inc. $693.00 1 $0 (2024)
Jazz Pharmaceuticals Inc. $136.37 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $693.00 1 EMD Serono, Inc. ($693.00)
2023 $136.37 1 Jazz Pharmaceuticals Inc. ($136.37)
2022 $2,700 2 ACADIA Pharmaceuticals Inc ($2,700)
2019 $8,031 33 ACADIA Pharmaceuticals Inc ($4,592)
2017 $4,504 8 Eisai Inc. ($4,504)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/04/2024 EMD Serono, Inc. — Consulting Fee Cash or cash equivalent $693.00 General
12/11/2023 Jazz Pharmaceuticals Inc. EPIDIOLEX (Drug) Food and Beverage In-kind items and services $136.37 General
Category: NEUROLOGY
04/18/2022 ACADIA Pharmaceuticals Inc — Consulting Fee Cash or cash equivalent $1,350.00 General
04/18/2022 ACADIA Pharmaceuticals Inc — Consulting Fee Cash or cash equivalent $1,350.00 General
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $687.40 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $687.40 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $125.80 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $105.47 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $105.47 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/12/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $51.75 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $343.70 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $111.43 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $111.43 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/11/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $60.00 Research
Study: ACP-2566-003
10/10/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $486.00 Research
Study: ACP-2566-003
10/10/2019 ACADIA Pharmaceuticals Inc — — In-kind items and services $430.00 Research
Study: ACP-2566-003
12»

Research Studies & Clinical Trials

Study Name Company Amount Records
ACP-2566-003 ACADIA Pharmaceuticals Inc $4,592 25

About Dr. Eric Marsh, M.D

Dr. Eric Marsh, M.D is a Pediatrics healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821012204.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Marsh, M.D has received a total of $16,064 in payments from pharmaceutical and medical device companies, with $693.00 received in 2024. These payments were reported across 45 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($9,536).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Neurology with Special Qualifications in Child Neurology, Clinical Neurophysiology
  • Location Philadelphia, PA
  • Active Since 07/27/2006
  • Last Updated 03/05/2015
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1821012204

Products in Payments

  • EPIDIOLEX (Drug) $136.37

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Philadelphia

Matthew Gillespie, M.d, M.D

Pediatrics — Payments: $1.5M

Pediatrics $1.5M

Stephan Grupp, M.d, M.D

Pediatrics — Payments: $472,209

Pediatrics $472,209

Oscar Mayer, M.d, M.D

Pediatrics — Payments: $270,148

Pediatrics $270,148

Robert Shaddy, Md, MD

Pediatrics — Payments: $148,516

Pediatrics $148,516

Michael Levine, Md, MD

Pediatrics — Payments: $137,530

Pediatrics $137,530

Michael Grunstein, M.d, M.D

Pediatrics — Payments: $133,646

Pediatrics $133,646